Zydus received FDA approval to conduct a Phase 2b trial testing usnoflast, its oral therapy for ALS, in 210 patients.
Karnataka: Shilpa Pharma Lifesciences Limited, a 100 percent subsidiary of Shilpa Medicare Limited has received certificate ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback